207 related articles for article (PubMed ID: 29428551)
1. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
Zhang S; Wang Y; Bondaruk J; Majewski T; Yao H; Lee S; Lee JG; Cogdell D; Lotan Y; Dinney C; Wei P; Baggerly K; Czerniak B
Eur Urol Focus; 2019 Jul; 5(4):664-675. PubMed ID: 29428551
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.
Ishiwata S; Takahashi S; Homma Y; Tanaka Y; Kameyama S; Hosaka Y; Kitamura T
Urology; 2001 Apr; 57(4):811-5. PubMed ID: 11306420
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
5. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
[TBL] [Abstract][Full Text] [Related]
6. Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).
Matsuyama H; Ikemoto K; Eguchi S; Oga A; Kawauchi S; Yamamoto Y; Kawai Y; Matsumoto H; Hara T; Nagao K; Sakano S; Sasaki K
BJU Int; 2014 Apr; 113(4):662-7. PubMed ID: 23890221
[TBL] [Abstract][Full Text] [Related]
7. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit).
Bravaccini S
Methods Mol Biol; 2021; 2292():35-48. PubMed ID: 33651350
[TBL] [Abstract][Full Text] [Related]
9. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
Bubendorf L; Grilli B; Sauter G; Mihatsch MJ; Gasser TC; Dalquen P
Am J Clin Pathol; 2001 Jul; 116(1):79-86. PubMed ID: 11447756
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
[TBL] [Abstract][Full Text] [Related]
11. Analysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancer.
Yoo JH; Suh B; Park TS; Shin MG; Choi YD; Lee CH; Choi JR
Cancer Genet Cytogenet; 2010 Apr; 198(2):107-17. PubMed ID: 20362225
[TBL] [Abstract][Full Text] [Related]
12. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer.
Junker K; Fritsch T; Hartmann A; Schulze W; Schubert J
Cytogenet Genome Res; 2006; 114(3-4):279-83. PubMed ID: 16954667
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.
Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
Eur Urol; 2002 Dec; 42(6):547-52. PubMed ID: 12477649
[TBL] [Abstract][Full Text] [Related]
14. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
Int J Urol; 2014 Oct; 21(10):968-72. PubMed ID: 24947145
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
19. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
20. Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer.
Skacel M; Liou LS; Pettay JD; Tubbs RR
Front Biosci; 2002 Jan; 7():e27-32. PubMed ID: 11779714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]